Additionally, the levels of SFRP4 in control group are significantly lower than those in T2DM, CHD and T2D+CHD, indicating that SFRP4 may be a predictive marker for atherosclerosis particularly in diabetic patients (162). This evidence concerns the gene SFRP4 and coronary artery disorder.